Conservative management of morbidly adherent placenta: expert review.
Over the last century, the incidence of placenta accreta, increta, and percreta, collectively referred to as morbidly adherent placenta, has risen dramatically. Planned cesarean hysterectomy at the time of cesarean delivery is the standard recommended treatment in the United States. Recently, interest in conservative management has resurged, especially in Europe. The aims of this review are the following: (1) to provide an overview of methods used for conservative management, (2) to discuss clinical implications for both clinicians and patients, and (3) to identify areas in need of further research.
Baylor College of Medicine, Houston, TX. Electronic address: kafox@bcm.edu.
Karin A
KA
Fox
Baylor College of Medicine, Houston, TX.
Alireza A
AA
Shamshirsaz
Harvard Medical School, Brigham and Women's Hospital.
Daniela
D
Carusi
Duke University Medical Center, Durham, NC.
Angeles Alvarez
AA
Secord
Duke University Medical Center, Durham, NC.
Paula
P
Lee
University of Maryland School of Medicine, Baltimore, MD.
Ozhan M
OM
Turan
Phoenix Perinatal Associates/Medivax, Banner Good Samaritan Medical Center, University of Arizona, Phoenix, AZ.
Christopher
C
Huls
Eastern Virginia Medical School, Norfolk, VA.
Alfred
A
Abuhamad
University of Pittsburgh School of Medicine, Pittsburgh, PA.
Hyagriv
H
Simhan
Baptist Health Lexington, Lexington, KY.
John
J
Barton
Columbia University College of Physicians and Surgeons, New York, NY.
Jason
J
Wright
University of Utah Medical School, Salt Lake City, UT.
Robert
R
Silver
Baylor College of Medicine, Houston, TX.
Michael A
MA
Belfort
D021721:Balloon Occlusion; D016063:Blood Loss, Surgical / Q000517:prevention & control; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007044:Hysterectomy; D015907:Hysteroscopy; D008026:Ligation; D008727:Methotrexate / Q000627:therapeutic use; D009215:Myometrium / Q000601:surgery; D059351:Organ Sparing Treatments; D010921:Placenta Accreta / Q000628:therapy*; D018457:Placenta, Retained / Q000628:therapy*; D019106:Postoperative Hemorrhage / Q000517:prevention & control; D006473:Postpartum Hemorrhage / Q000517:prevention & control; D011247:Pregnancy; D011296:Prenatal Diagnosis; D061665:Time-to-Treatment; D055988:Uterine Artery / Q000601:surgery; D055357:Uterine Artery Embolization
D004791:Enzyme Inhibitors; D008727:Methotrexate
accreta; conservative management; increta; percreta